Co-Expression of Vascular Endothelial Growth Factor and Its Receptor flt-1 in Malignant Pleural Mesothelioma

Publisher： Karger

E-ISSN： 1423-0356|67|1|36-40

ISSN： 0025-7931

Source： Respiration, Vol.67, Iss.1, 2000-02, pp. : 36-40

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gene delivery of soluble vascular endothelial growth factor receptor-1 (sFlt-1) inhibits intra-plaque angiogenesis and suppresses development of atherosclerotic plaque

By Wang Yaosheng  

Clinical and Experimental Medicine, Vol. 11, Iss. 2, 2011-06 ,pp. : 113-121

Springer Publishing Company

Access to resources Recommend Favorite

Interleukin-1 Receptor Antagonist Inhibits the Expression of Vascular Endothelial Growth Factor in Colorectal Carcinoma

By  

Oncology, Vol. 68, Iss. 2-3, 2005-07 ,pp. : 138-145

Karger

Access to resources Recommend Favorite

High Level of Vascular Endothelial Growth Factor in Hemorrhagic Pleural Effusion of Cancer

By  

Oncology, Vol. 63, Iss. 1, 2002-08 ,pp. : 70-75

Karger

Access to resources Recommend Favorite

In vitro study of normoxic epidermal growth factor receptor–induced hypoxia‐inducible factor‐1‐alpha, vascular endothelial growth factor, and BNIP3 expression in head and neck squamous cell carcinoma cell lines: Implications for anti–epidermal growth factor receptor therapy

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 8, 2015-08 ,pp. : 1150-1162

John Wiley & Sons Inc

Access to resources Recommend Favorite

Role of transcription factor Sp1 in the quercetin-mediated inhibitory effect on human malignant pleural mesothelioma

By                

International Journal of Molecular Medicine, Vol. 30, Iss. 4, 2012-01 ,pp. : 835-841

Spandidos Publications

Access to resources Recommend Favorite